Cases & Deals

Biotheranostics establishes trademark rights for its BREAST CANCER INDEX and CancerTYPE ID tests

Clients Biotheranostics, Inc.

Jones Day is assisting Biotheranostics, Inc., a commercial-stage molecular diagnostics company, with the branding for its prognostic and predictive tests that support physicians in the treatment of cancer. The Firm’s work includes trademark prosecution and management for Biotheranostics’ portfolio that includes the BREAST CANCER INDEX and CancerTYPE ID trademarks.